Oct 30, 2026, 5:13 PMBiopharma Stocks
Lilly, Gilead and J&J Hit Record Highs Amid Tech Wreck
Eli Lilly, Gilead Sciences and Johnson & Johnson shares keep hitting record highs as biopharma emerges as a winner from the technology stock selloff now.
Listen to this briefingAudio briefing
Summary
MarketWatch reported on October 30, 2026, that shares of large drugmakers Lilly, Gilead and Johnson & Johnson continue to reach record highs. Its headline presents biopharma stocks as major beneficiaries of the technology-sector selloff.
Only a short feed summary was available. It provided no share prices, percentage gains, valuation measures, earnings data, drug catalysts or timeframe for the records, leaving the rally’s scale and causes unspecified.
Positives
- Lilly shares continue to reach record highs, according to the October 30, 2026 feed summary.
- Gilead shares are also repeatedly setting records as large drugmakers outperform during the technology selloff.
- Johnson & Johnson joins Lilly and Gilead at record highs, broadening the reported strength across large biopharma companies.
Risks & concerns
- The feed supplied no share prices or percentage gains, preventing measurement of the reported outperformance.
- No timeframe was given for the record highs, limiting historical comparison.
- The summary identified no earnings, pipeline, regulatory or transaction catalysts behind the rally.
Primary sourceMarketWatch.com - Top Storieshttps://www.marketwatch.com/story/the-big-winners-of-the-tech-wreck-are-biopharma-stocks-2ac4d175?mod=mw_rss_topstories
Read full article
